Recombinant MAPT (Tilavonemab Biosimilar) 抗体
The Humanized Chimeric anti-MAPT (Tilavonemab Biosimilar) antibody is suitable to detect MAPT (Tilavonemab Biosimilar) in samples from 人. It has been validated for ELISA 和 WB.
产品编号 ABIN7538070
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant MAPT (Tilavonemab Biosimilar) 抗体 (ABIN7538070)
抗原
MAPT (Tilavonemab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Humanized
克隆类型
Chimeric
标记
This MAPT (Tilavonemab Biosimilar) antibody is un-conjugated
应用范围
ELISA, Western Blotting (WB)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Tilavonemab Biosimilar - Anti-MAPT mAb - Research Grade
-
产品特性
- Antibody Type: IgG4-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
纯度
- > 85%
-
亚型
- IgG4
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS buffer PH7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- MAPT (Tilavonemab Biosimilar)
-
物质类
- Biosimilar
-
背景
- Tilavonemab is a humanised anti-tau antibody that binds amino acids 25-30 near the N-terminal end of the tau protein. Tilavonemab blocks the ability of human and mouse neurons to take up tau aggregates and reduces brain atrophy. Tilavonemab can be used in the study of Alzheimer's disease.
-
CAS-编号
- 2096513-89-0
抗原
-
You are here:
